Humanized anti-CD26 monoclonal antibody as a treatment for malignant mesothelioma tumors

Teruo Inamoto, Taketo Yamada, Kei Ohnuma, Shinichiro Kina, Nozomu Takahashi, Tadanori Yamochi, Sakiko Inamoto, Yoji Katsuoka, Osamu Hosono, Hirotoshi Tanaka, Nam H. Dang, Chikao Morimoto

Research output: Contribution to journalArticlepeer-review

67 Citations (Scopus)

Fingerprint Dive into the research topics of 'Humanized anti-CD26 monoclonal antibody as a treatment for malignant mesothelioma tumors'. Together they form a unique fingerprint.

Medicine & Life Sciences